OSI Pharmaceuticals INC
SEC CIK 729922 · OSIP · last insider filing 2010-06-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Costa Santo J | Director | filed 2006–2010 |
| Niemiec David W | Director | filed 2006–2010 |
| Klein Joseph III | Director | filed 2006–2010 |
| Ingram Robert Alexander | Director | filed 2006–2010 |
| Goddard Colin | Director · Chief Executive Officer | filed 2006–2010 |
| Stevenson Katharine Berghuis | Director | filed 2006–2010 |
| Mehta Viren | Director | filed 2006–2010 |
| White John P | Director | filed 2006–2010 |
| Pinedo Herbert MD PHD | Director | filed 2006–2010 |
| Friedman Linda F. | Director | filed 2010–2010 |
| Shea Patrick Michael | Director | filed 2010–2010 |
| Knowles Stephen | Director | filed 2010–2010 |
| Fitzsimmons William E. | Director | filed 2010–2010 |
| LEE Kenneth B JR | Director | filed 2007–2010 |
| Granner Daryl K | Director | filed 2006–2009 |
| Browne G Morgan | Director | filed 2006–2007 |
| Lovenberg Walter M PHD | Director | filed 2006–2007 |
| Richmond Mark | Director | filed 2006–2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Simon Robert L | Exec. VP, Pharm. Dev. & Manf. | filed 2006–2010 |
| Wood Barbara A | V.P. & General Counsel | filed 2006–2010 |
| Leung Gabriel | Exec. VP, Pres., (OSI) Onc. | filed 2006–2010 |
| Lundemose Anker MD, PH.D, DSC | Exec. VP & Pres. OSI Prosidion | filed 2006–2010 |
| Epstein David M. | Sr. VP and CSO, Oncology | filed 2010–2010 |
| Davies Angela M. | Sr. VP and CMO, Oncology | filed 2010–2010 |
| Amper Linda E | VP Bus. Administration & HR | filed 2007–2010 |
| Legault Pierre | Exec. VP, CFO & Treasurer | filed 2009–2010 |
| Rachman Jonathan | Sr VP, Diabetes/Obesity R&D | filed 2009–2010 |
| Atieh Michael G | Exec. VP & CFO | filed 2006–2008 |
| Gibson Neil | VP & Chief Scientific Officer | filed 2006–2007 |
| Cagnoni Pablo J | VP & Chief Medical Officer | filed 2006–2006 |
| Chaney Paul G | Exec. VP & Pres. (OSI) Eyetech | filed 2006–2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.